Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Organogenesis Holdings Inc.’s reported figures.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s EBIT?
- Organogenesis Holdings Inc. (ORGO) reported EBIT of -$50.99M in Q2 2026.
- How has Organogenesis Holdings Inc.'s EBIT changed year-over-year?
- Organogenesis Holdings Inc.'s EBIT decreased by 305.5% year-over-year, from -$12.58M to -$50.99M.
- What is the long-term trend for Organogenesis Holdings Inc.'s EBIT?
- Over 2 years (2021 to 2025), Organogenesis Holdings Inc.'s EBIT has grown at a -21.3% compound annual growth rate (CAGR), from $72.22M to $44.69M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Organogenesis Holdings Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude